intravenous immunoglobulin
intravenous immunoglobulin is a pharmaceutical drug with 42 clinical trials. Currently 8 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 18 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
18
Mid Stage
13
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
69.2%
18 of 26 finished
30.8%
8 ended early
8
trials recruiting
42
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
IVIG Trial for the Treatment of Bronchopulmonary Dysplasia
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Clinical Trials (42)
Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
IVIG Trial for the Treatment of Bronchopulmonary Dysplasia
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)
Transplant Antibody-Mediated Rejection: Guiding Effective Treatments
IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2
Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
A Trial Comparing the Efficacy and Safety of Anakinra Versus Intravenous Immunoglobulin (IVIG) Retreatment, in Patients With Kawasaki Disease Who Failed to Respond to Initial Standard IVIG Treatment
IVIG in Painful Sensory Neuropathy
IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3
Evaluate the Efficacy and Safety of Various Treatment Schemes for Severe Fever With Thrombocytopenia Syndrome(SFTS)
IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients
IVIg Plus Low Dose rhTPO for ITP in Pregnancy
Effect of Pre-emptive Intravenous Immunoglobulin (IVIG) on the Incidence of Septic Episodes in Pediatric Burn Patients
A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)
IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements
The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia
A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 42